This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988 Jul-Sep;8(3):353-91.

doi: 10.1002/med.2610080303.

Cognition activators

W H Moos¹, R E Davis, R D Schwarz, E R Gamzu

Affiliations

PMID: 3043116
DOI: 10.1002/med.2610080303

Review

Cognition activators

W H Moos et al. Med Res Rev. 1988 Jul-Sep.

. 1988 Jul-Sep;8(3):353-91.

doi: 10.1002/med.2610080303.

Authors

W H Moos¹, R E Davis, R D Schwarz, E R Gamzu

Affiliation

¹ Department of Chemistry, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105.

PMID: 3043116
DOI: 10.1002/med.2610080303

No abstract available

PubMed Disclaimer

Similar articles

Trends in searching for new cognition enhancing drugs.
Merlini L, Pinza M. Merlini L, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 Suppl:S61-75. doi: 10.1016/0278-5846(89)90111-5. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2694230 Review.
Psychopharmacology and Alzheimer's disease.
Serby M. Serby M. J Adv Med Surg Nurs. 1989 Mar;1(2):32-9. J Adv Med Surg Nurs. 1989. PMID: 2664071 Review. No abstract available.
Alzheimer dementia: Starting, stopping drug therapy.
Kim LD, Factora RM. Kim LD, et al. Cleve Clin J Med. 2018 Mar;85(3):209-214. doi: 10.3949/ccjm.85a.16080. Cleve Clin J Med. 2018. PMID: 29522388 Review.
[Challenging pharmacotherapy in dementia].
Ihl R. Ihl R. MMW Fortschr Med. 2009 Mar 26;151(13):46-8. MMW Fortschr Med. 2009. PMID: 19504818 German. No abstract available.
Therapeutic lying to assist people with dementia in maintaining medication adherence.
Mitchell G. Mitchell G. Nurs Ethics. 2014 Nov;21(7):844-5. doi: 10.1177/0969733014543886. Nurs Ethics. 2014. PMID: 25355415 No abstract available.

See all similar articles

Cited by

Effect of the nootropic drug oxiracetam on field potentials of rat hippocampal slices.
Pugliese AM, Corradetti R, Ballerini L, Pepeu G. Pugliese AM, et al. Br J Pharmacol. 1990 Jan;99(1):189-93. doi: 10.1111/j.1476-5381.1990.tb14676.x. Br J Pharmacol. 1990. PMID: 1970492 Free PMC article.
Effect of a new nootropic agent, CGS 5649B, on cognition, function, and behavior in dementia.
Molloy DW, Guyatt GH, Standish T, Willan A, McIlroy W, D'Souza J, Brown G, Mondadori C. Molloy DW, et al. J Gen Intern Med. 1993 Aug;8(8):444-7. doi: 10.1007/BF02599624. J Gen Intern Med. 1993. PMID: 8410411 Clinical Trial.
Development of pharmacological treatments for Alzheimer-type dementia.
Cornwall J, Corn TH. Cornwall J, et al. J R Soc Med. 1994;87 Suppl 23(Suppl 23):19-21. J R Soc Med. 1994. PMID: 8064767 Free PMC article. Review. No abstract available.
Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.
Sarter M, Hagan J, Dudchenko P. Sarter M, et al. Psychopharmacology (Berl). 1992;107(2-3):144-59. doi: 10.1007/BF02245132. Psychopharmacology (Berl). 1992. PMID: 1615119 Review.
Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
Triggle DJ, Kwon YW, Abraham P, Rahman MA, Carroll FI. Triggle DJ, et al. Pharm Res. 1992 Nov;9(11):1474-9. doi: 10.1023/a:1015871131913. Pharm Res. 1992. PMID: 1475236

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database